Jiangsu Lintex Advanced Materials
920106
Beijing Chieftain Control Technology Group
300430
Jiangsu Apon Medical Technology
300753
Fujian Zitian Media Technology
300280
SigmaStar Technology
301536
CN Stock MarketDetailed Quotes
600488 Tianjin Tianyao Pharmaceuticals
- 4.53
- +0.03+0.67%
Not Open Dec 18 15:00 CST
4.95BMarket Cap32.59P/E (TTM)
4.57High4.47Low79.99KlotVolume4.51Open4.50Pre Close36.18MTurnover0.73%Turnover Ratio42.34P/E (Static)1.09BShares5.0052wk High1.62P/B4.95BFloat Cap3.0152wk Low4.95Limit Up1.09BShs Float12.99Historical High4.05Limit Down2.22%Amplitude0.98Historical Low0.09Dividend TTM4.52Avg Price33.49KlotAsk1.92%Div YieldTTM100Lot Size45.35KlotBid
Tianjin Tianyao Pharmaceuticals Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -2.67%2.4B | -4.56%1.63B | -3.71%785.11M | -1.55%3.42B | -0.73%2.47B | 11.49%1.71B | 36.12%815.38M | 9.25%3.48B | 15.73%2.49B | 12.18%1.53B |
| Refunds of taxes and levies | 24.25%103.66M | 33.08%65.87M | 46.71%32.41M | 1.04%114.23M | 0.30%83.43M | -9.68%49.5M | -18.74%22.09M | 24.07%113.05M | 32.72%83.18M | 38.26%54.8M |
| Net deposit increase | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Net increase in borrowings from central bank | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Net increase in placements from other financial institutions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash received from interests, fees and commissions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Net increase in repurchase business capital | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Premiums received from original insurance contracts | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Net cash received from reinsurance business | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Net increase in deposits from policyholders | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Net increase in funds disbursed | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Net cash received from trading securities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash received relating to other operating activities | -32.69%49.01M | -40.59%34.96M | 0.59%16.65M | 9.64%97.34M | -10.81%72.82M | -6.32%58.84M | -67.40%16.55M | -10.43%88.79M | -1.41%81.65M | -10.72%62.81M |
| Cash inflows from operating activities | -2.64%2.56B | -4.70%1.73B | -2.32%834.17M | -1.20%3.64B | -1.01%2.62B | 10.11%1.81B | 26.15%854.02M | 9.08%3.68B | 15.57%2.65B | 11.79%1.65B |
| Goods services cash paid | -6.14%1.34B | -10.14%902.54M | 16.54%501.8M | -14.51%1.88B | -10.95%1.43B | -2.09%1B | 9.85%430.58M | -2.24%2.2B | 7.60%1.61B | 4.05%1.03B |
| Staff behalf paid | 26.63%394.68M | 33.93%271.97M | 52.96%169.29M | 5.34%427.12M | 12.87%311.67M | 12.92%203.07M | 13.70%110.68M | 5.38%405.45M | 5.59%276.12M | 4.29%179.83M |
| All taxes paid | -10.97%211.54M | -10.82%144.7M | -5.20%71.83M | 10.21%308.66M | 9.91%237.61M | 12.25%162.25M | 5.36%75.77M | 7.60%280.06M | 17.88%216.18M | 42.38%144.54M |
| Net loan and advance increase | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Net deposit in central bank and institutions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Net lend capital | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash paid for fees and commissions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash paid for indemnity of original insurance contract | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Policy dividend cash paid | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash paid relating to other operating activities | -15.32%151.91M | -28.29%93.29M | -27.08%39.7M | 66.39%238.36M | 79.70%179.39M | 80.86%130.09M | 21.65%54.44M | -12.56%143.25M | -24.87%99.82M | -26.12%71.93M |
| Cash outflows from operating activities | -2.70%2.1B | -5.82%1.41B | 16.55%782.62M | -5.73%2.85B | -1.79%2.16B | 5.46%1.5B | 10.80%671.46M | -1.00%3.03B | 6.18%2.2B | 4.78%1.42B |
| Net cash flows from operating activities | -2.37%454.35M | 0.66%315.83M | -71.76%51.55M | 19.81%783.01M | 2.77%465.39M | 39.52%313.76M | 157.12%182.56M | 106.23%653.52M | 102.63%452.86M | 93.57%224.89M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash received from returns on investments | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 1,818.90%500.95K | --85.83K | ---- | -74.77%1.03M | --26.11K | --0 | ---- | 494.52%4.07M | ---- | ---- |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash inflows from investing activities | 1,818.90%500.95K | --85.83K | ---- | -74.77%1.03M | --26.11K | --0 | ---- | 0.30%4.07M | ---- | ---- |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -43.51%50.82M | -24.08%37.16M | -12.47%24.12M | -34.15%133.15M | -35.01%89.97M | -49.62%48.95M | -49.73%27.56M | -45.48%202.2M | -51.54%138.44M | -51.11%97.16M |
| Cash paid to acquire investments | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Impawned loan net increase | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash paid relating to other investing activities | --400K | --400K | --400K | --0 | --0 | --0 | --0 | --0 | ---- | ---- |
| Cash outflows from investing activities | -43.07%51.22M | -23.26%37.56M | -11.02%24.52M | -34.15%133.15M | -35.01%89.97M | -49.62%48.95M | -49.73%27.56M | -46.93%202.2M | -53.20%138.44M | -53.49%97.16M |
| Net cash flows from investing activities | 43.61%-50.72M | 23.43%-37.48M | 11.02%-24.52M | 33.32%-132.12M | 35.03%-89.94M | 49.62%-48.95M | 49.73%-27.56M | 47.44%-198.13M | 52.58%-138.44M | 53.43%-97.16M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash from borrowing | 31.79%765.01M | -17.08%427.45M | 80.36%101M | -47.15%580.5M | -47.15%580.5M | -4.25%515.5M | -30.35%56M | -28.05%1.1B | -23.76%1.1B | -41.91%538.4M |
| Cash received relating to other financing activities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | -11.43%155M | -11.43%155M | 6.90%155M |
| Cash inflows from financing activities | 31.79%765.01M | -17.08%427.45M | 80.36%101M | -53.69%580.5M | -53.69%580.5M | -25.66%515.5M | -69.80%56M | -26.34%1.25B | -22.38%1.25B | -35.31%693.4M |
| Borrowing repayment | -4.98%944.59M | -15.40%617.53M | -11.48%130.5M | -13.83%995.57M | -13.85%994.07M | 8.28%729.93M | -7.92%147.43M | -4.44%1.16B | -2.44%1.15B | -5.87%674.1M |
| Dividend interest payment | 260.23%158.29M | 281.53%110.36M | -8.77%8.33M | -15.34%67M | -20.78%43.94M | -12.15%28.93M | 3.09%9.13M | 7.13%79.15M | 22.26%55.47M | 1.50%32.92M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | 1.92%19.25M | ---- | ---- | ---- | 20.61%18.89M | --8.8M | ---- |
| Cash payments relating to other financing activities | -94.12%4.87M | -99.91%70.99K | -99.90%28.41K | 12.60%82.78M | 90.22%82.78M | 90.22%82.78M | 742.70%27.28M | -77.45%73.52M | -85.54%43.52M | -82.66%43.52M |
| Cash outflows from financing activities | -1.16%1.11B | -13.51%727.96M | -24.46%138.86M | -12.43%1.15B | -10.54%1.12B | 12.14%841.63M | 6.76%183.83M | -18.70%1.31B | -18.06%1.25B | -24.91%750.54M |
| Net cash flows from financing activities | 36.56%-342.74M | 7.86%-300.51M | 70.38%-37.86M | -935.01%-564.85M | -92,076.63%-540.29M | -470.77%-326.13M | -1,068.14%-127.83M | -158.88%-54.57M | -99.32%587.42K | -179.01%-57.14M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 332.07%12.82M | 207.77%11.68M | 484.29%6.11M | 1,284.50%8.17M | -143.73%-5.53M | -218.26%-10.84M | -227.49%-1.59M | -55.49%589.81K | 3,075.59%12.64M | 6,514.15%9.17M |
| Net increase in cash and cash equivalents | 143.26%73.71M | 85.48%-10.48M | -118.47%-4.72M | -76.53%94.2M | -152.00%-170.37M | -190.47%-72.16M | -16.51%25.57M | 1,082.25%401.41M | 1,743.96%327.65M | 493.28%79.76M |
| Add:Begin period cash and cash equivalents | 15.47%703.01M | 15.47%703.01M | 15.47%703.01M | 193.55%608.8M | 193.55%608.8M | 193.55%608.8M | 193.55%608.8M | 19.58%207.4M | 19.58%207.4M | 19.58%207.4M |
| End period cash equivalent | 77.16%776.72M | 29.05%692.53M | 10.07%698.28M | 15.47%703.01M | -18.06%438.43M | 86.89%536.65M | 166.51%634.38M | 193.55%608.8M | 179.82%535.04M | 87.48%287.15M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit China Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | China Audit China Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.